The inaugural ADPKD guideline from KDIGO provides updated recommendations on therapies to slow disease progression, including the use of tolvaptan. In January 2025, Kidney Disease: Improving ...
Medpage Today on MSN9mon
Many Patients With CKD Never Receive a Diagnosis"In the most recent CKD Guidelines from KDIGO, they recognize and talk about this group and actually recommend physicians ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.
The prevalence of CKD among patients being cared for by general practitioners is approximately 30%, and its prevalence in nursing homes is over 50%. An S3 guideline has been developed for the ...
a company dedicated to addressing acute kidney injury through real-time renal assessment based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines with the Accuryn Monitoring System ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback